Thermo Fisher Scientific is a global leader in providing scientific instruments, reagents, and consumables, with a focus on advancing healthcare, life sciences, and laboratory workflows. The company supports a diverse range of customers, including researchers, clinical laboratories, and pharmaceutical companies, by offering innovative solutions that enable breakthroughs in areas such as diagnostics, drug development, and environmental analysis. With a commitment to quality and efficiency, Thermo Fisher Scientific plays a crucial role in enhancing productivity and scientific discovery across various disciplines while promoting better health outcomes worldwide. Read More
Life sciences company Thermo Fisher (NYSE:TMO) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 3% year on year to $10.86 billion. Its non-GAAP profit of $5.36 per share was 2.5% above analysts’ consensus estimates.
Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Shares of life sciences company Thermo Fisher (NYSE:TMO)
jumped 12.3% in the afternoon session after the company reported second-quarter earnings and revenue that surpassed Wall Street estimates and raised its full-year financial guidance. The company posted adjusted earnings per share (EPS) of $5.36 on revenue of $10.85 billion. These results topped the average analyst estimates, which had projected an EPS of $5.22 on revenue of $10.65 billion. EPS is a widely used metric of a company's profitability. Following the strong quarterly performance, Thermo Fisher lifted its outlook for the full year. The company now expected 2025 revenue to be between $43.6 billion and $44.2 billion, raising the lower end of its previous forecast. It also increased its adjusted EPS guidance to a range of $22.22 to $22.84. The better-than-expected results were driven by growth in its Life Sciences Solutions and Lab Products & Biopharma Services divisions.
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Stephen Williamson, senior vice president and chief financial officer (CFO), has decided to retire from the company, effective March 31, 2026. The company’s board of directors has approved the appointment of Jim Meyer, currently vice president of financial operations, to succeed Williamson as CFO, effective March 1, 2026.
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3% year on year to $10.86 billion. Its non-GAAP profit of $5.36 per share was 2.3% above analysts’ consensus estimates.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 28, 2025.
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
